Charles River Laboratories International, Inc. (CRL)
273.41
+0.53
(+0.19%)
USD |
NYSE |
Sep 16, 16:00
273.41
0.00 (0.00%)
After-Hours: 19:13
Charles River Laboratories International Enterprise Value : 15.89B for Sept. 15, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 15.89B |
| September 14, 2026 | 15.90B |
| September 11, 2026 | 16.15B |
| September 10, 2026 | 15.90B |
| September 09, 2026 | 16.15B |
| September 08, 2026 | 16.27B |
| September 04, 2026 | 16.64B |
| September 03, 2026 | 16.87B |
| September 02, 2026 | 16.79B |
| September 01, 2026 | 16.34B |
| August 31, 2026 | 16.62B |
| August 28, 2026 | 16.78B |
| August 27, 2026 | 17.01B |
| August 26, 2026 | 16.95B |
| August 25, 2026 | 17.07B |
| August 24, 2026 | 17.12B |
| August 21, 2026 | 16.96B |
| August 20, 2026 | 16.78B |
| August 19, 2026 | 16.71B |
| August 18, 2026 | 16.19B |
| August 17, 2026 | 16.55B |
| August 14, 2026 | 16.23B |
| August 13, 2026 | 16.29B |
| August 12, 2026 | 16.44B |
| August 11, 2026 | 16.33B |
| Date | Value |
|---|---|
| August 10, 2026 | 16.09B |
| August 07, 2026 | 15.63B |
| August 06, 2026 | 15.54B |
| August 05, 2026 | 15.31B |
| August 04, 2026 | 14.04B |
| August 03, 2026 | 13.89B |
| July 31, 2026 | 13.96B |
| July 30, 2026 | 14.06B |
| July 29, 2026 | 14.07B |
| July 28, 2026 | 14.34B |
| July 27, 2026 | 13.57B |
| July 24, 2026 | 13.68B |
| July 23, 2026 | 13.81B |
| July 22, 2026 | 13.30B |
| July 21, 2026 | 13.34B |
| July 20, 2026 | 13.35B |
| July 17, 2026 | 13.57B |
| July 16, 2026 | 13.80B |
| July 15, 2026 | 13.76B |
| July 14, 2026 | 13.90B |
| July 13, 2026 | 13.83B |
| July 10, 2026 | 14.01B |
| July 09, 2026 | 14.02B |
| July 08, 2026 | 13.56B |
| July 07, 2026 | 13.78B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IQVIA Holdings, Inc. | 58.68B |
| Medpace Holdings, Inc. | 16.92B |
| Fortrea Holdings, Inc. | 2.825B |
| Champions Oncology, Inc. | 73.57M |
| Avantor, Inc. | 13.84B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.76M |
| Revenue (Quarterly) | 1.004B |
| Total Expenses (Quarterly) | 1.006B |
| EPS Diluted (Quarterly) | -0.0309 |
| Gross Profit Margin (Quarterly) | 36.29% |
| Profit Margin (Quarterly) | -0.08% |
| Earnings Yield | -1.77% |
| Operating Earnings Yield | 4.04% |
| Normalized Earnings Yield | 0.6882 |